Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study

• Main Authors: Hiroshi Nomoto (Author), Kenichi Kito (Author), Hiroshi Iesaka (Author), Yuki Oe (Author), Shinichiro Kawata (Author), Kazuhisa Tsuchida (Author), Shingo Yanagiya (Author), Aika Miya (Author), Hiraku Kameda (Author), Kyu Yong Cho (Author), Ichiro Sakuma (Author), Naoki Manda (Author), Akinobu Nakamura (Author), Tatsuya Atsumi (Author)
• Format: Book
• Published: MDPI AG, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator, has beneficial effects on lipid metabolism. However, its effects on glucose metabolism in individuals with type 2 diabetes (T2DM) remain to be fully clarified. This was a subanalysis of the PARM-T2D study, a multice...